Last10K.com

Heska Corp (HSKA) SEC Filing 10-K Annual report for the fiscal year ending Thursday, December 31, 2020

Heska Corp

HISTORY TOOLS
CIK: 1038133 Ticker: HSKA

Exhibit 99.1
Heska Corporation
heskalogoa051a.jpg
Jon Aagaard
Investor Relations
970.619.3033
investorrelations@heska.com

Heska Corporation Reports Fourth Quarter and Full Year 2020 Results
Full Year Sales Up 60.9% - Fourth Quarter Sales Up 90.5% - Full Year Subscriptions Up 25%
2021 Outlook Revenue Raised, Key Strategic Initiatives Reaffirmed

LOVELAND, CO, February 23, 2021 -- Heska Corporation (NASDAQ: HSKA; “Heska” or “Company”), a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its fourth quarter and full year ended December 31, 2020. Point of Care is "POC" and scil animal care company GmbH is "scil" in this release. The scil acquisition was completed April 1, 2020.
Fourth Quarter and Full Year 2020 and Year Over Year ("YOY") Metrics
$ in millions except Earnings Per Share ("EPS")

Q4 ($)Q4 (%) YOYFY ($)FY (%) YOY
Consolidated Revenue$64.390.5%$197.360.9%
North America Revenue$40.029.3%$131.113.6%
International Revenue$24.3
1
$66.3
1
Q4 (%)
Q4 YOY bps2
FY (%)
FY YOY bps2
Consolidated Gross Margin41.3%-56041.2%-320
Net income (loss) margin3
4.5%960(7.1)%-620
Adjusted EBITDA Margin4
13.4%22011.3%280
Q4Q4 (%) YOYFYFY (%) YOY
Net income (loss) attributable to Heska$2.5
1
$(14.4)
1
EPS, Diluted$0.25
1
$(1.66)
1
Non-GAAP EPS, Diluted4
$0.72
1
$0.7451.0%

1 Comparable percentage variances are not meaningful because of the impact of acquisitions. 2 "bps" is basis points. 3 Net income (loss) used for comparison represents the "Net income (loss) before equity in losses of unconsolidated affiliates." 4 See “Use of Non-GAAP Financial Measures” and related reconciliations provided below.
Fourth Quarter and Full Year 2020 Highlights
•Record quarterly and annual revenue growth.
•North America POC Lab Consumables sales up 15.5% in Q4. Up 11.2% year-over-year, ahead of 2020 Outlook (8%-10%).

The following information was filed by Heska Corp (HSKA) on Tuesday, February 23, 2021 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Heska Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Heska Corp.

Continue

Assess how Heska Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Heska Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
M & A
Revenue
Legal
Other
Filter Subcategory:
All
Earnings
Income
Product
Cash Flow
Geography
Shares
Expense
Other
Inside Heska Corp's 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Cover
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Income
Consolidated Statements Of Stockholders' Equity
Accrued Liabilities
Accrued Liabilities (Details)
Accrued Liabilities (Tables)
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income (Details)
Accumulated Other Comprehensive Income (Tables)
Acquisition And Related Party Items
Acquisition And Related Party Items - Additional Information (Details)
Acquisition And Related Party Items - Fair Value Of Assets And Liabilities At Cvm Acquisition Date (Details)
Acquisition And Related Party Items - Fair Values Of Assets And Liabilties At Scil Acquisition Date (Details)
Acquisition And Related Party Items - Intangible Assets Acquired, Amortization Method (Details)
Acquisition And Related Party Items - Unaudited Pro Forma Financial Information (Details)
Acquisition And Related Party Items Acquisition And Related Party Items (Tables)
Capital Stock
Capital Stock (Tables)
Capital Stock - Narrative (Details)
Capital Stock - Option Activity (Details)
Capital Stock Capital Stock - Restricted Stock (Details)
Capital Stock- Summary Of Information By Exercise Price Range (Details)
Commitments And Contingencies
Commitments And Contingencies (Details)
Convertible Note Receivable
Convertible Note Receivable (Details)
Convertible Note Receivable (Tables)
Convertible Note Receivable - Additional Information (Details)
Credit Facility And Long-Term Debt
Credit Facility And Long-Term Debt Credit Facility And Long-Term Debt (Tables)
Credit Facility And Long-Term Debt Credit Facility And Long-Term Debt - Carrying Amount Of Debt (Details)
Credit Facility And Long-Term Debt Credit Facility And Long-Term Debt - Interest Expense Related To The Notes (Details)
Credit Facility And Long-Term Debt Credit Facility And Long-Term Debt - Narrative (Details)
Earnings Per Share
Earnings Per Share (Details)
Earnings Per Share (Tables)
Goodwill And Other Intangibles
Goodwill And Other Intangibles (Details)
Goodwill And Other Intangibles (Tables)
Income Taxes
Income Taxes (Details)
Income Taxes (Tables)
Income Taxes - Components Of Income (Loss) Before Taxes (Details)
Income Taxes - Components Of Income Tax Expense (Benefit) (Details)
Income Taxes - Effective Income Tax Reconciliation (Details)
Income Taxes - Temporary Differences To The Components Of Deferred Tax Assets (Details)
Income Taxes - Unrecognized Tax Benefits Roll Forward (Details)
Interest And Other (Income) Expense, Net
Interest And Other (Income) Expense, Net (Details)
Interest And Other (Income) Expense, Net (Tables)
Inventories
Inventories (Details)
Inventories (Tables)
Investments In Unconsolidated Affiliates
Investments In Unconsolidated Affiliates (Details)
Investments In Unconsolidated Affiliates (Tables)
Leases
Leases (Tables)
Leases - Additional Information (Details)
Leases - Lessee Accounting (Details)
Leases - Lessor Accounting (Details)
Leases - Operating And Financing Lease Balances (Details)
Leases - Sales-Type Leases And Lease Income (Details)
Leases - Supplemental Cash Flow Information (Details)
Leases - Weighted Average Remaining Lease Term And Weighted Average Discount Rate (Details)
Operations And Summary Of Significant Accounting Policies
Operations And Summary Of Significant Accounting Policies (Details)
Operations And Summary Of Significant Accounting Policies (Policies)
Operations And Summary Of Significant Accounting Policies (Tables)
Property And Equipment
Property And Equipment (Details)
Property And Equipment (Tables)
Revenue
Revenue (Details)
Revenue (Tables)
Revenue - Performance Obligations (Details)
Segment Reporting
Segment Reporting (Details)
Segment Reporting (Tables)
Subsequent Events
Subsequent Events (Details)
Ticker: HSKA
CIK: 1038133
Form Type: 10-K Annual Report
Accession Number: 0001038133-21-000011
Submitted to the SEC: Fri Feb 26 2021 10:30:41 AM EST
Accepted by the SEC: Fri Feb 26 2021
Period: Thursday, December 31, 2020
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/hska/0001038133-21-000011.htm